Aignostics, a spin-off of Charité – Universitätsmedizin Berlin and alumnus of the Berlin Institute of Health Digital Health Accelerator Program, has been named to Newsweek’s inaugural ranking of the “World’s Best Digital Health Companies 2024.”
On 28 February 2024, the team from Charité BIH Innovation (CBI) - the joint technology transfer of Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) - was delighted to receive a visit from Prof. Heyo. K. Kroemer, Chairman of the Executive Board of Charité, Prof. Dr Joachim Spranger, Dean of Charité, Prof. Dr Christopher…
Twice a year, the start-up competition Gründungswettbewerb – Digitale Innovationen by the Federal Ministry for Economic Affairs and Climate Protection's (BMWK) honors the best ideas of innovative start-ups that are based on digital technologies. The award supports start-ups in the early stages and emphasizes their key role as drivers of innovation…
On May 31, 2023, the sixth annual Demo Day of the BIH Digital Health Accelerator Program took place, bringing together a diverse group of innovative minds in the heart of Berlin. The event, hosted by the Berlin Institute of Health at Charité (BIH), showcased seven exceptional teams of Charité/BIH clinicians and researchers presenting their digital…
An interdisciplinary team led by Prof. Angela Relógio, a scientist at Charité’s Molecular Cancer Research Center (MKFZ) and Institute for Theoretical Biology and the MSH Medical School Hamburg, has developed a non-invasive method for profiling a person’s unique circadian rhythm. Starting with a simple saliva sample, the team of experts can create a…
Not only the DNA sequence – our genome – but also the 3D structure of our genome – the 'epi-genome' – is essential in determining the type and function of a cell. That's why the analysis of the epigenome facilitates deep insights into the developmental history of a cell and its current gene expression profile, but also allows deductions on its…
Research of Molecular Epidemiology Unit at the Berlin Institute of Health and the Charité is focused on epigenetic modifications that occur in close interaction between the individual genetic background and environmental exposure and potentially contribute to increased disease risks. Thereby, we are in particular interested to identify key events…
On January 24 in Berlin, four innovation teams from the Digital Health Accelerator pilot project of Berlin Institute of Health (BIH) and two start-ups from Charité – Universitätsmedizin Berlin presented their digital health solutions for everyday clinical use. The new solutions leverage in particular imaging and big data big data analytical…
Berlin Institute of Health (BIH) offers digital health innovators co-working space and expertise